サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ドラベ症候群の世界市場（2023年～2032年）：市場シェア、規模、動向、業界分析、発作タイプ別、診断別、重症度別、治療法別、最終用途別、流通チャネル別、地域別、セグメント予測
市場調査レポート
商品コード
1238770

ドラベ症候群の世界市場（2023年～2032年）：市場シェア、規模、動向、業界分析、発作タイプ別、診断別、重症度別、治療法別、最終用途別、流通チャネル別、地域別、セグメント予測

Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures ; By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 126 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ドラベ症候群の世界市場（2023年～2032年）：市場シェア、規模、動向、業界分析、発作タイプ別、診断別、重症度別、治療法別、最終用途別、流通チャネル別、地域別、セグメント予測
出版日: 2023年02月01日
発行: Polaris Market Research
ページ情報: 英文 126 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のドラベ症候群の市場規模は、2032年までに5億5,717万米ドルに達すると予想されています。

当レポートでは、世界のドラベ症候群市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポートについて
    • 調査目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データ情報源
    • 一次情報源
    • 二次情報源

第4章 世界のドラベ症候群市場：洞察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力（中）
    • 新規参入者の脅威（低）
    • 買い手の交渉力（中）
    • 代替の脅威（中）
    • 既存企業間の競争（高）
  • PESTLE分析
  • 業界の動向
  • COVID-19の影響分析

第5章 世界のドラベ症候群市場：診断別

  • 主な調査結果
  • イントロダクション
    • 診断別の世界市場（2019年～2032年）
  • MRI
    • MRI別、地域別（2019年～2032年）
  • ECG
    • ECG別、地域別（2019年～2032年）
  • SCN1Aテスト
    • SCN1Aテスト別、地域別（2019年～2032年）

第6章 世界のドラベ症候群市場：重症度別

  • 主な調査結果
  • イントロダクション
    • 重症度別の世界市場（2019年～2032年）
  • 軽症
    • 軽症別、地域別（2019年～2032年）
  • 中等症
    • 中等症別、地域別（2019年～2032年）
  • 重症
    • 重症別、地域別（2019年～2032年）

第7章 世界のドラベ症候群市場：治療法別

  • 主な調査結果
  • イントロダクション
    • 治療法別の世界市場（2019年～2032年）
  • 発作
    • 発作別、地域別（2019年～2032年）
  • 投薬
    • 投薬別、地域別（2019年～2032年）
  • クロバザム
    • クロバザム別、地域別（2019年～2032年）
  • スチリペントール
    • スチリペントール別、地域別（2019年～2032年）
  • バルプロ酸ナトリウム
    • バルプロ酸ナトリウム別、地域別（2019年～2032年）
  • その他
    • その他別、地域別（2019年～2032年）
  • ケトジェニックダイエット
    • ケトジェニックダイエット別、地域別（2019年～2032年）
  • 迷走神経刺激
    • 迷走神経刺激別、地域別（2019年～2032年）

第8章 世界のドラベ症候群市場：流通チャネル別

  • 主な調査結果
  • イントロダクション
    • 流通チャネル別の世界市場（2019年～2032年）
  • 直接入札
    • 直接入札別、地域別（2019年～2032年）
  • 病院薬局
    • 病院薬局別、地域別（2019年～2032年）
  • 小売薬局
    • 小売薬局別、地域別（2019年～2032年）
  • その他
    • その他別、地域別（2019年～2032年）

第9章 世界のドラベ症候群市場：発作タイプ別

  • 主な調査結果
  • イントロダクション
    • 発作タイプ別の世界市場（2019年～2032年）
  • ミオクロニー発作
    • ミオクロニー発作別、地域別（2019年～2032年）
  • アトニック発作
    • アトニック発作別、地域別（2019年～2032年）
  • 部分発作
    • 部分発作別、地域別（2019年～2032年）
  • 強直間代発作
    • 強直間代発作別、地域別（2019年～2032年）
  • 感光性発作
    • 感光性発作別、地域別（2019年～2032年）
  • その他
    • その他別、地域別（2019年～2032年）

第10章 世界のドラベ症候群市場：最終用途別

  • 主な調査結果
  • イントロダクション
    • 最終用途別の世界市場（2019年～2032年）
  • 製薬企業
    • 製薬企業別、地域別（2019年～2032年）
  • 病院
    • 病院別、地域別（2019年～2032年）
  • 診断検査室
    • 診断検査室別、地域別（2019年～2032年）
  • 学術研究機関
    • 学術研究機関別、地域別（2019年～2032年）
  • その他
    • その他別、地域別（2019年～2032年）

第11章 世界のドラベ症候群市場：地域別

  • 主な調査結果
  • イントロダクション
    • ドラベ症候群市場の評価：地域（2019年～2032年）
  • 北米
    • 診断別
    • 流通チャネル別
    • 重症度別
    • 発作タイプ別
    • 治療法別
    • 最終用途別
    • 米国
    • カナダ
  • 欧州
    • 診断別
    • 流通チャネル別
    • 重症度別
    • 発作タイプ別
    • 治療法別
    • 最終用途別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • 診断別
    • 流通チャネル別
    • 重症度別
    • 発作タイプ別
    • 治療法別
    • 最終用途別
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 診断別
    • 流通チャネル別
    • 重症度別
    • 発作タイプ別
    • 治療法別
    • 最終用途別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 診断別
    • 流通チャネル別
    • 重症度別
    • 発作タイプ別
    • 治療法別
    • 最終用途別
    • メキシコ
    • ブラジル
    • アルゼンチン

第12章 競合情勢

  • 拡大と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/協定/展示会

第13章 企業プロファイル

  • Biscayne Neurotherapeutics
  • Epygenix Therapeutics
  • OPKO Health
  • GW Pharmaceuticals
  • Ovid Therapeutics
  • PTC Therapeutics
  • Sage Therapeutics
  • INSYS Therapeutics
  • Takeda Pharmaceutical
  • ThermoFisher Life
  • Xenon Pharmaceutical
  • Zogenix Inc.
図表

List of Tables

  • Table 1 Global Dravet Syndrome Market, by Diagnosis, by Region, 2019-2032 (USD Million)
  • Table 2 Global Dravet Syndrome Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 3 Global Dravet Syndrome Market, by Severity, by Region, 2019-2032 (USD Million)
  • Table 4 Global Dravet Syndrome Market, by Type of seizures, by Region, 2019-2032 (USD Million)
  • Table 5 Global Dravet Syndrome Market, by Treatment, by Region, 2019-2032 (USD Million)
  • Table 6 Global Dravet Syndrome Market, by End-Use, by Region, 2019-2032 (USD Million)
目次
Product Code: PM3033

The global dravet syndrome market size is expected to reach USD 557.17 million by 2032, according to a new study by Polaris Market Research. The report "Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of seizures (Myoclonic seizures, Atonic seizures, Partial seizures, Tonic-clonic seizures, photosensitive seizures Others); By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market's revenue growth will most likely be driven by enhanced genetic testing, which has increased the probability of Dravet syndrome diagnosis. An increase in improved regulatory environment for the healthcare sector and government funding for R&D has contributed to growth in the revenue of market. Improved healthcare infrastructure and greater healthcare budgets are expected to promote market revenue growth during the projected period. Increasing R&D initiatives for the discovery of innovative medications for syndrome are projected to drive growth in the future.

The U.S. FDA authorized the approval of the Diacomit in August 2020, for treating seizures linked with Dravet syndrome. Drug market share is expected to expand significantly after 2020 as a result of improved efficiency, safety, & longer seizure relief. Dravet syndrome is an exceedingly unusual neurological disorder that is typically lifelong. According to the Dravet Foundation, 1 in every 15,700 newborns born in the United States has Dravet syndrome.

Encoded's precision gene therapy seeks to treat gait issues, ataxia (poor coordination), and developmental delays. It is intended to treat mutations in the SCN1A gene, which are the cause of the majority of Dravet cases, by increasing endogenous SCN1A expression in a particular cell type in the brain. The therapy increased SCN1A expression in a subset of inhibitory interneurons. Encoded intends to begin clinical trials for the therapy in early 2021. As numerous rich nations face a failure of these specifics, the increased demand for COVID-19 operation curatives has created enormous eventualities for manufacturers. Because of the need for vaccinations and treatment specifics for COVID-19, biopharma assiduity is likely to increase significantly in future. This, in turn, is projected to have a major influence on the dravet syndrome market as an effect of COVID-19.

Dravet Syndrome Market Report Highlights:

  • Myoclonic Seizures held the largest revenue share as it affects both sides of the brain simultaneously. It is widely used for children with Dravet syndrome and other epileptic conditions.
  • The hospital pharmacies lead the market segment because of the availability and accessibility of innovative therapies and equipment.
  • The global players include: Biscayne, Cyberonics, INSYS Therapeutics, Epygenix Therapeutics, GW Pharmaceuticals, Ovid Therapeutics, PTC Therapeutics, Sage Therapeutics, Takeda Pharmaceutical, ThermoFisher Life, OPKO Health, Xenon Pharmaceutical, and Zogenix.

Polaris Market Research has segmented the Dravet syndrome market report based on form type of seizures, diagnosis, severity, treatment, end-use, distribution channel, and region:

Dravet Syndrome, Type of seizures Outlook (Revenue - USD Million, 2019 - 2032)

  • Myoclonic Seizures
  • Atonic Seizures
  • Partial Seizures
  • Tonic-Clonic Seizures
  • Photosensitive seizures
  • Others

Dravet Syndrome, Diagnosis Outlook (Revenue - USD Million, 2019 - 2032)

  • MRI
  • EEG
  • SCN1A testing

Dravet Syndrome, Severity Outlook (Revenue - USD Million, 2019 - 2032)

  • Mild
  • Moderate
  • Severe

Dravet Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Seizure Medication
  • Clobazam
  • Stiripentol
  • Sodium Valproate
  • Others
  • Ketogenic Diet
  • Vagus Nerve Stimulation

Dravet Syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical companies
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Others

Dravet Syndrome, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Direct tender
  • Hospital pharmacy
  • Retail Pharmacy
  • Others

Dravet Syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dravet Syndrome Market Insights

  • 4.1. Dravet Syndrome - Industry Snapshot
  • 4.2. Dravet Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased government investment in R&D
      • 4.2.1.2. Availability of favorable reimbursement policies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Drug-related adverse effects and the high cost of existing treatments.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Dravet Syndrome Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Dravet Syndrome Market, by Diagnosis

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  • 5.3. MRI
    • 5.3.1. Global Dravet Syndrome Market, by MRI, by Region, 2019-2032 (USD Million)
  • 5.4. ECG
    • 5.4.1. Global Dravet Syndrome Market, by ECG, by Region, 2019-2032 (USD Million)
  • 5.5. SCN1A testing
    • 5.5.1. Global Dravet Syndrome Market, by SCN1A testing, by Region, 2019-2032 (USD Million)

6. Global Dravet Syndrome Market, by Severity

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  • 6.3. Mild
    • 6.3.1. Global Dravet Syndrome Market, by Mild, by Region, 2019-2032 (USD Million)
  • 6.4. Moderate
    • 6.4.1. Global Dravet Syndrome Market, by Moderate, by Region, 2019-2032 (USD Million)
  • 6.5. Severe
    • 6.5.1. Global Dravet Syndrome Market, by Severe, by Region, 2019-2032 (USD Million)

7. Global Dravet Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Seizure
    • 7.3.1. Global Dravet Syndrome Market, by Seizure, by Region, 2019-2032 (USD Million)
  • 7.4. Medication
    • 7.4.1. Global Dravet Syndrome Market, by Medication, by Region, 2019-2032 (USD Million)
  • 7.5. Clobazam
    • 7.5.1. Global Dravet Syndrome Market, by Clobazam, by Region, 2019-2032 (USD Million)
  • 7.6. Stiripentol
    • 7.6.1. Global Dravet Syndrome Market, by Stiripentol, by Region, 2019-2032 (USD Million)
  • 7.7. Sodium Valproate
    • 7.7.1. Global Other Dravet Syndrome Market, by Sodium Valproate, by Region, 2019-2032 (USD Million)
  • 7.8. Others
    • 7.8.1. Global Other Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)
  • 7.9. Ketogenic diet
    • 7.9.1. Global Other Dravet Syndrome Market, by Ketogenic diet, by Region, 2019-2032 (USD Million)
  • 7.10. Vagus Nerve stimulation
    • 7.10.1. Global Other Dravet Syndrome Market, by Vagus Nerve stimulation, by Region, 2019-2032 (USD Million)

8. Global Dravet Syndrome Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.3. Direct Tender
    • 8.3.1. Global Dravet Syndrome Market, by Direct Tender, by Region, 2019-2032 (USD Million)
  • 8.4. Hospital pharmacy
    • 8.4.1. Global Dravet Syndrome Market, by Hospital pharmacy, by Region, 2019-2032 (USD Million)
  • 8.5. Retail Pharmacy
    • 8.5.1. Global Dravet Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Dravet Syndrome Market, by Type of seizures

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  • 9.3. Myoclonic Seizures
    • 9.3.1. Global Dravet Syndrome Market, by Myoclonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.4. Atonic Seizures
    • 9.4.1. Global Dravet Syndrome Market, by Atonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.5. Partial Seizures
    • 9.5.1. Global Dravet Syndrome Market, by Partial Seizures, by Region, 2019-2032 (USD Million)
  • 9.6. Tonic-Clonic Seizures
    • 9.6.1. Global Dravet Syndrome Market, by Tonic-Clonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.7. Photosensitive seizures
    • 9.7.1. Global Dravet Syndrome Market, by Photosensitive seizures, by Region, 2019-2032 (USD Million)
  • 9.8. Others
    • 9.8.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

10. Global Dravet Syndrome Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 10.3. Pharma companies
    • 10.3.1. Global Dravet Syndrome Market, by Pharma companies, by Region, 2019-2032 (USD Million)
  • 10.4. Hospitals
    • 10.4.1. Global Dravet Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 10.5. Diagnostic Laboratories
    • 10.5.1. Global Dravet Syndrome Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
  • 10.6. Academic and Research Institutes
    • 10.6.1. Global Dravet Syndrome Market, by Academic and Research Institutes, by Region, 2019-2032 (USD Million)
  • 10.7. Others
    • 10.7.1. Global Other End-Uses Dravet Syndrome Market, by Region, 2019-2032 (USD Million)

11. Global Dravet Syndrome Market, by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Dravet Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 11.3. Dravet Syndrome Market - North America
    • 11.3.1. North America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.3.2. North America: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.3.3. North America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.3.4. North America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.3.5. North America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.3.6. North America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.3.7. Dravet Syndrome Market - U.S.
      • 11.3.7.1. U.S.: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.3.7.2. U.S.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.3.7.3. U.S.: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.3.7.4. U.S.: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.3.7.5. U.S.: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.3.7.6. U.S.: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.3.8. Dravet Syndrome Market - Canada
      • 11.3.8.1. Canada: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.3.8.2. Canada.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.3.8.3. Canada: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.3.8.4. Canada: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.3.8.5. Canada: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.3.8.6. Canada: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.4. Dravet Syndrome Market - Europe
    • 11.4.1. Europe: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.4.2. Europe.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.4.3. Europe: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.4.4. Europe: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.4.5. Europe: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.4.6. Europe: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.7. Dravet Syndrome Market - UK
      • 11.4.7.1. UK: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.7.2. UK.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.7.3. UK: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.7.4. UK: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.7.5. UK: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.7.6. UK: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.8. Dravet Syndrome Market - France
      • 11.4.8.1. France: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.8.2. France.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.8.3. France: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.8.4. France: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.8.5. France: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.8.6. France: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.9. Dravet Syndrome Market - Germany
      • 11.4.9.1. Germany: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.9.2. Germany.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.9.3. Germany: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.9.4. Germany: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.9.5. Germany: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.9.6. Germany: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.10. Dravet Syndrome Market - Italy
      • 11.4.10.1. Italy: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.10.2. Italy.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.10.3. Italy: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.10.4. Italy: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.10.5. Italy: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.10.6. Italy: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.11. Dravet Syndrome Market - Spain
      • 11.4.11.1. Spain: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.11.2. Spain.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.11.3. Spain: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.11.4. Spain: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.11.5. Spain: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.11.6. Spain: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.12. Dravet Syndrome Market - Netherlands
      • 11.4.12.1. Netherlands: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.12.2. Netherlands.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.12.3. Netherlands: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.12.4. Netherlands: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.12.5. Netherlands: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.12.6. Netherlands: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.13. Dravet Syndrome Market - Russia
      • 11.4.13.1. Russia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.13.2. Russia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.13.3. Russia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.13.4. Russia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.13.5. Russia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.13.6. Russia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.5. Dravet Syndrome Market - Asia Pacific
    • 11.5.1. Asia Pacific: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.5.2. Asia Pacific.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.5.3. Asia Pacific: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.5.4. Asia Pacific: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.5.5. Asia Pacific: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.5.6. Asia Pacific: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.7. Dravet Syndrome Market - China
      • 11.5.7.1. China: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.7.2. China.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.7.3. China: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.7.4. China: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.7.5. China: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.7.6. China: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.8. Dravet Syndrome Market - India
      • 11.5.8.1. India: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.8.2. India.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.8.3. India: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.8.4. India: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.8.5. India: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.8.6. India: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.9. Dravet Syndrome Market - Japan
      • 11.5.9.1. Japan: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.9.2. Japan.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.9.3. Japan: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.9.4. Japan: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.9.5. Japan: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.9.6. Japan: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.10. Dravet Syndrome Market - Malaysia
      • 11.5.10.1. Malaysia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.10.2. Malaysia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.10.3. Malaysia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.10.4. Malaysia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.10.5. Malaysia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.10.6. Malaysia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.11. Dravet Syndrome Market - Indonesia
      • 11.5.11.1. Indonesia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.11.2. Indonesia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.11.3. Indonesia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.11.4. Indonesia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.11.5. Indonesia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.11.6. Indonesia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.12. Dravet Syndrome Market - South Korea
      • 11.5.12.1. South Korea: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.12.2. South Korea.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.12.3. South Korea: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.12.4. South Korea: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.12.5. South Korea: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.12.6. South Korea: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.6. Dravet Syndrome Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.6.2. Middle East & Africa: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.6.3. Middle East & Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.6.4. Middle East & Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.6.5. Middle East & Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.6.6. Middle East & Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.7. Dravet Syndrome Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.7.2. Saudi Arabia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.7.3. Saudi Arabia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.7.4. Saudi Arabia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.7.5. Saudi Arabia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.7.6. Saudi Arabia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.8. Dravet Syndrome Market - UAE
      • 11.6.8.1. UAE: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.8.2. UAE.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.8.3. UAE: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.8.4. UAE: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.8.5. UAE: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.8.6. UAE: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.9. Dravet Syndrome Market - Israel
      • 11.6.9.1. Israel: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.9.2. Israel.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.9.3. Israel: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.9.4. Israel: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.9.5. Israel: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.9.6. Israel: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.10. Dravet Syndrome Market - South Africa
      • 11.6.10.1. South Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.10.2. South Africa.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.10.3. South Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.10.4. South Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.10.5. South Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.10.6. South Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.7. Dravet Syndrome Market - Latin America
    • 11.7.1. Latin America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.7.2. Latin America.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.7.3. Latin America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.7.4. Latin America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.7.5. Latin America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.7.6. Latin America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.7. Dravet Syndrome Market - Mexico
      • 11.7.7.1. Mexico: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.7.2. Mexico.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.7.3. Mexico: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.7.4. Mexico: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.7.5. Mexico: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.7.6. Mexico: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.8. Dravet Syndrome Market - Brazil
      • 11.7.8.1. Brazil: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.8.2. Brazil.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.8.3. Brazil: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.8.4. Brazil: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.8.5. Brazil: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.8.6. Brazil: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.9. Dravet Syndrome Market - Argentina
      • 11.7.9.1. Argentina: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.9.2. Argentina.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.9.3. Argentina: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.9.4. Argentina: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.9.5. Argentina: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.9.6. Argentina: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Biscayne Neurotherapeutics
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Epygenix Therapeutics
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. OPKO Health
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. GW Pharmaceuticals
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Ovid Therapeutics
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. PTC Therapeutics
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. Sage Therapeutics
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. INSYS Therapeutics
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Takeda Pharmaceutical
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. ThermoFisher Life
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. Xenon Pharmaceutical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Zogenix Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development